The IBD Clinic: Continuity of Care in IBD - From Diagnosis to Management

Adam S. Cheifetz, MD, graduated magna cum laude from Brown University before earning his M.D. from Cornell University Medical College. Dr. Cheifetz completed his internship and residency in Internal Medicine at Yale-New Haven Hospital and his fellowship in Gastroenterology at Yale University before serving as the Present-Levinson Fellow in Inflammatory Bowel Disease at the Mount Sinai Medical Center in New York City.
 
Dr. Cheifetz is Director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and Associate Professor of Medicine at Harvard Medical School. He is Director of the Harvard Medical School Gastroenterology Clerkship Elective and Assistant Director of the Advanced Fellowship in Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center.
 
Dr. Cheifetz specializes in the treatment of Crohn's disease, ulcerative colitis, and other inflammatory bowel diseases. For the last eight years, Dr. Cheifetz has been cited in Boston Magazine as one of Boston's Top Doctors. In addition to his clinical work, he is involved in multiple research projects relating to IBD and has published over 100 articles and chapters on the subject. His research currently focuses on optimizing the use of biologics through the proactive use of drug concentrations and antibodies. Dr. Cheifetz lectures nationally and internationally on IBD.  
 
Dr. Cheifetz is also actively involved with teaching and mentoring medical students, residents, and fellows and is proud to have trained numerous physicians who now specialize in IBD. In addition, he serves on numerous editorial boards including Inflammatory Bowel Diseases, Journal of Clinical Gastroenterology, Journal of Crohn's and Colitis, and the World Journal of Gastroenterology.
 
Dr. Cheifetz has been involved with the CCFA for over 10 years on both a regional and national level. He is a long-time member of the New England Chapter Medical Advisory Committee and is the immediate past Chairman. He was recently named the NE Chapter CCFA 2015 Humanitarian of the Year. In addition, he serves on the National Scientific Advisory Committee and at this time is Co-Chairman of the CCFA Membership Committee.

Uma Mahadevan, MD, completed a medical degree at the State University of New York in Brooklyn. She completed residency in internal medicine at Mount Sinai Medical Center in New York, a fellowship in gastroenterology at the University of California, San Francisco (UCSF), and a fellowship in inflammatory bowel disease (IBD) at the Mayo Clinic in Rochester, Minnesota. Dr. Mahadevan currently serves as Professor of Medicine at UCSF and Co-Medical Director of the UCSF Center for Colitis and Crohn's Disease and Director of the IBD Fellowship.
 
Certified by the American Board of Internal Medicine as a diplomate in internal medicine and gastroenterology, Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she is a vice-chair for the Clinical Immunology, Microbiology and Inflammatory Bowel Disease (IMIBD) Section and co-director of the 2017 Post-Graduate Course. She is also a fellow of the American College of Gastroenterology for which she is chair of IBD for the 2017 ACG course and a member of the Educational Affairs Committee. She is currently co-chair of the CCFA Clinical Research Grants committee and a member of their National Scientific Advisory Committee.
 
Dr. Mahadevan is a special section editor for Gastroenterology and an editorial board member and reviewer for several other journals. Dr. Mahadevan has published original articles, abstracts, editorials, and invited reviews in such peer-reviewed journals as Gastroenterology, Gut, American Journal of Gastroenterology and Inflammatory Bowel Diseases along with several book chapters. Dr. Mahadevan specializes in the treatment of ulcerative colitis, Crohn's disease, and pouchitis. She has a particular interest in pregnancy and fertility in IBD, as well as in clinical trials of experimental therapy for both ulcerative colitis and Crohn's disease. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO), clinical trials in biologic therapy for IBD, and microbiome, environmental and dietary changes.

David A. Schwartz, MD, is Professor of Medicine in the Division of Gastroenterology, Hepatology, and Nutrition at Vanderbilt University in Nashville, Tennessee. He founded and currently serves as Director of the Inflammatory Bowel Disease Center at Vanderbilt University Medical Center.
 
Dr. Schwartz received his postgraduate training at the Mayo Clinic in Rochester, Minnesota, where he completed a fellowship in Gastroenterology and Hepatology, and advanced training in Inflammatory Bowel Disease and Endoscopic Ultrasound. He is a Fellow of the American College of Gastroenterology and the American Gastroenterological Association.
 
Dr. Schwartz's research has focused on clinical trials for inflammatory bowel disease, imaging of inflammatory bowel disease, the multidisciplinary care of the IBD patient, and the treatment of perianal Crohn's disease. He has lectured extensively throughout the United States and has written more than 200 articles, book chapters, and abstracts.

Robin Dalal, MD, graduated from the Medical College of Georgia in Augusta, Georgia, and completed her internal medicine residency at Vanderbilt University Medical Center in Nashville, Tennessee. She served a year as Chief Resident in internal medicine at Vanderbilt prior to starting fellowship in gastroenterology and hepatology.
 
Dr. Dalal is currently a gastroenterology fellow at Vanderbilt. She has recently accepted a faculty position at Vanderbilt University Medical Center and will start in the summer of 2017.
 
Dr. Dalal's clinical interest is in inflammatory bowel disease (IBD). She has presented and lectured at multiple meetings, conferences, and events across the country. Dr. Dalal is a member of the Crohn's and Colitis Foundation of America, the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy.